|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
A Phase II Study of Weekly
Irinotecan as First-Line Therapy for Patients with Metastatic
Pancreatic Cancer Cancer Chemother Pharmacol. 2006
Jul 20; PMID: 16855842 |
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |